Literature DB >> 33502692

Tc-99m pyrophosphate left atrial uptake in patients with atrial fibrillation and cardiac amyloidosis.

Rami M Abazid1, Jonathan G Romsa2, James C Warrington2, Robert Z Stodilka2, Ryan A Davey3, Sabe De3, David L Laidley2, William C Vezina2, Cigdem Akincioglu2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33502692     DOI： 10.1007/s12350-020-02508-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   3.872


× No keyword cloud information.
  2 in total

1.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Authors:  Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H Falk; Victor A Ferrari; Marianna Fontana; Olivier Gheysens; Julian D Gillmore; Andor W J M Glaudemans; Mazen A Hanna; Bouke P C Hazenberg; Arnt V Kristen; Raymond Y Kwong; Mathew S Maurer; Giampaolo Merlini; Edward J Miller; James C Moon; Venkatesh L Murthy; C Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Sanjiv J Shah; Riemer H J A Slart; Hein J Verberne; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2019-12       Impact factor: 5.952

2.  Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role.

Authors:  Simone Longhi; Candida Cristina Quarta; Agnese Milandri; Massimiliano Lorenzini; Christian Gagliardi; Lisa Manuzzi; Maria Letizia Bacchi-Reggiani; Ornella Leone; Alessandra Ferlini; Antonio Russo; Ilaria Gallelli; Claudio Rapezzi
Journal:  Amyloid       Date:  2015-06-05       Impact factor: 7.141
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.